SAN DIEGO, Sept. 22, 2025 /PRNewswire/ -- Building on its leadership in point-of-care diagnostic testing, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading global provider of ...
QuidelOrtho Corporation is broadening its point-of-care diagnostic offerings with the launch of the QUICKVUE Influenza + SARS ...
Designed for symptomatic individuals within six days of symptom onset, the QuickVue COVID-19 test is cleared for use in individuals aged 14 or older when self-testing, and in those aged two and older ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback